pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Radiopharmaceuticals Market Report 2017


Published On : Aug 2017

Category : Pharmaceutical

No. of Pages : 111 pages

  • $4000
  • $8000

Please click below to avail discount on this report

In this report, the EMEA Radiopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Radiopharmaceuticals for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Radiopharmaceuticals market competition by top manufacturers/players, with Radiopharmaceuticals sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into
Diagnostic Radioisotopes
Therapeutic Radioisotopes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Doses), market share and growth rate of Radiopharmaceuticals for each application, including
Oncology
Cardiology
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

In the recent times, the global market for Emea europe middle east and africa radiopharmaceuticals market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Emea europe middle east and africa radiopharmaceuticals market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Emea europe middle east and africa radiopharmaceuticals market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the Emea europe middle east and africa radiopharmaceuticals market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Emea europe middle east and africa radiopharmaceuticals market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Emea europe middle east and africa radiopharmaceuticals market report 2017, including the definition, classification, and industry chain structure of Emea europe middle east and africa radiopharmaceuticals market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Emea europe middle east and africa radiopharmaceuticals market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Emea europe middle east and africa radiopharmaceuticals market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Emea europe middle east and africa radiopharmaceuticals market report 2017, implemented in each of the geographical segments. The predominant applications of the Emea europe middle east and africa radiopharmaceuticals market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Emea europe middle east and africa radiopharmaceuticals market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Emea europe middle east and africa radiopharmaceuticals market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Radiopharmaceuticals
Figure EMEA Radiopharmaceuticals Sales Volume (K Doses) by Type (2012-2022)
Figure EMEA Radiopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Radioisotopes Product Picture
Figure Therapeutic Radioisotopes Product Picture
Figure EMEA Radiopharmaceuticals Sales Volume (K Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Radiopharmaceuticals by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Radiopharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure Europe Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Radiopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Radiopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Africa Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Radiopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Radiopharmaceuticals Sales Volume and Growth Rate (2012-2022)
Figure EMEA Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Radiopharmaceuticals Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table EMEA Radiopharmaceuticals Sales Volume (K Doses) of Major Players (2012-2017)
Table EMEA Radiopharmaceuticals Sales Share by Players (2012-2017)
Figure 2016 Radiopharmaceuticals Sales Share by Players
Figure 2017 Radiopharmaceuticals Sales Share by Players
Figure EMEA Radiopharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Radiopharmaceuticals Revenue (Million USD) by Players (2012-2017)
Table EMEA Radiopharmaceuticals Revenue Share by Players (2012-2017)
Table 2016 EMEA Radiopharmaceuticals Revenue Share by Players
Table 2017 EMEA Radiopharmaceuticals Revenue Share by Players
Table EMEA Radiopharmaceuticals Sale Price (USD/Dose) by Players (2012-2017)
Table EMEA Radiopharmaceuticals Sales (K Doses) and Market Share by Type (2012-2017)
Table EMEA Radiopharmaceuticals Sales Share by Type (2012-2017)
Figure Sales Market Share of Radiopharmaceuticals by Type (2012-2017)
Figure EMEA Radiopharmaceuticals Sales Market Share by Type (2012-2017)
Table EMEA Radiopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Radiopharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals by Type in 2016
Table EMEA Radiopharmaceuticals Sale Price (USD/Dose) by Type (2012-2017)
Table EMEA Radiopharmaceuticals Sales (K Doses) and Market Share by Application (2012-2017)
Table EMEA Radiopharmaceuticals Sales Share by Application (2012-2017)
Figure Sales Market Share of Radiopharmaceuticals by Application (2012-2017)
Figure EMEA Radiopharmaceuticals Sales Market Share by Application in 2016
Table EMEA Radiopharmaceuticals Sales (K Doses) and Market Share by Region (2012-2017)
Table EMEA Radiopharmaceuticals Sales Share by Region (2012-2017)
Figure Sales Market Share of Radiopharmaceuticals by Region (2012-2017)
Figure EMEA Radiopharmaceuticals Sales Market Share in 2016
Table EMEA Radiopharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Radiopharmaceuticals Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals by Region (2012-2017)
Figure EMEA Radiopharmaceuticals Revenue Market Share Regions in 2016
Table EMEA Radiopharmaceuticals Sales Price (USD/Dose) by Region (2012-2017)
Figure Europe Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Europe Radiopharmaceuticals Revenue and Growth Rate (2012-2017)
Table Europe Radiopharmaceuticals Sales (K Doses) by Type (2012-2017)
Table Europe Radiopharmaceuticals Market Share by Type (2012-2017)
Figure Europe Radiopharmaceuticals Market Share by Type in 2016
Table Europe Radiopharmaceuticals Sales (K Doses) by Application (2012-2017)
Table Europe Radiopharmaceuticals Market Share by Application (2012-2017)
Figure Europe Radiopharmaceuticals Market Share by Application in 2016
Table Europe Radiopharmaceuticals Sales (K Doses) by Countries (2012-2017)
Table Europe Radiopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceuticals Sales Market Share by Countries in 2016
Table Europe Radiopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Europe Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceuticals Revenue Market Share by Countries in 2016
Figure Germany Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure France Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure UK Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Russia Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Italy Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Benelux Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Radiopharmaceuticals Sales (K Doses) by Type (2012-2017)
Table Middle East Radiopharmaceuticals Market Share by Type (2012-2017)
Figure Middle East Radiopharmaceuticals Market Share by Type (2012-2017)
Table Middle East Radiopharmaceuticals Sales (K Doses) by Applications (2012-2017)
Table Middle East Radiopharmaceuticals Market Share by Applications (2012-2017)
Figure Middle East Radiopharmaceuticals Sales Market Share by Application in 2016
Table Middle East Radiopharmaceuticals Sales Volume (K Doses) by Countries (2012-2017)
Table Middle East Radiopharmaceuticals Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Radiopharmaceuticals Sales Volume Market Share by Countries in 2016
Table Middle East Radiopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Middle East Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Radiopharmaceuticals Revenue Market Share by Countries in 2016
Figure Saudi Arabia Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Israel Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure UAE Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Iran Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Radiopharmaceuticals Sales (K Doses) by Type (2012-2017)
Table Africa Radiopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Radiopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Radiopharmaceuticals Sales Market Share by Type in 2016
Table Africa Radiopharmaceuticals Sales (K Doses) by Application (2012-2017)
Table Africa Radiopharmaceuticals Sales Market Share by Application (2012-2017)
Figure Africa Radiopharmaceuticals Sales Market Share by Application (2012-2017)
Table Africa Radiopharmaceuticals Sales Volume (K Doses) by Countries (2012-2017)
Table Africa Radiopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceuticals Sales Market Share by Countries in 2016
Table Africa Radiopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Africa Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceuticals Revenue Market Share by Countries in 2016
Figure South Africa Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Nigeria Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Egypt Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Algeria Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Table Bracco Imaging Radiopharmaceuticals Basic Information List
Table Bracco Imaging Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Bracco Imaging Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Bracco Imaging Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Bracco Imaging Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Bayer Radiopharmaceuticals Basic Information List
Table Bayer Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Bayer Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Bayer Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Bayer Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Mallinckrodt Radiopharmaceuticals Basic Information List
Table Mallinckrodt Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Mallinckrodt Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Mallinckrodt Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Mallinckrodt Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Nordion Radiopharmaceuticals Basic Information List
Table Nordion Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Nordion Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Nordion Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Nordion Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Triad Isotopes Radiopharmaceuticals Basic Information List
Table Triad Isotopes Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Triad Isotopes Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Triad Isotopes Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Triad Isotopes Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Lantheus Radiopharmaceuticals Basic Information List
Table Lantheus Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Lantheus Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Lantheus Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Lantheus Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table IBA Group Radiopharmaceuticals Basic Information List
Table IBA Group Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure IBA Group Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure IBA Group Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure IBA Group Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table GE Healthcare Radiopharmaceuticals Basic Information List
Table GE Healthcare Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure GE Healthcare Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure GE Healthcare Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure GE Healthcare Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table China Isotope & Radiation Radiopharmaceuticals Basic Information List
Table China Isotope & Radiation Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure China Isotope & Radiation Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure China Isotope & Radiation Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure China Isotope & Radiation Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Jubilant Pharma Radiopharmaceuticals Basic Information List
Table Jubilant Pharma Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Jubilant Pharma Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2017)
Figure Jubilant Pharma Radiopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Jubilant Pharma Radiopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Radiopharmaceuticals Basic Information List
Table Advanced Accelerator Applications Radiopharmaceuticals Basic Information List
Table SIEMENS Radiopharmaceuticals Basic Information List
Table Dongcheng Radiopharmaceuticals Basic Information List
Table Navidea Radiopharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radiopharmaceuticals
Figure Manufacturing Process Analysis of Radiopharmaceuticals
Figure Radiopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Radiopharmaceuticals Major Manufacturers in 2016
Table Major Buyers of Radiopharmaceuticals
Table Distributors/Traders List
Figure EMEA Radiopharmaceuticals Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Radiopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Radiopharmaceuticals Price (USD/Dose) and Trend Forecast (2017-2022)
Table EMEA Radiopharmaceuticals Sales (K Doses) Forecast by Region (2017-2022)
Figure EMEA Radiopharmaceuticals Sales Market Share Forecast by Region (2017-2022)
Table EMEA Radiopharmaceuticals Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Radiopharmaceuticals Revenue Market Share Forecast by Region (2017-2022)
Table Europe Radiopharmaceuticals Sales (K Doses) Forecast by Countries (2017-2022)
Figure Europe Radiopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Europe Radiopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Radiopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Radiopharmaceuticals Sales (K Doses) Forecast by Countries (2017-2022)
Figure Middle East Radiopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Radiopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Radiopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Radiopharmaceuticals Sales (K Doses) Forecast by Countries (2017-2022)
Figure Africa Radiopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Africa Radiopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Radiopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Radiopharmaceuticals Sales (K Doses) Forecast by Type (2017-2022)
Figure EMEA Radiopharmaceuticals Sales Market Share Forecast by Type (2017-2022)
Table EMEA Radiopharmaceuticals Sales (K Doses) Forecast by Application (2017-2022)
Figure EMEA Radiopharmaceuticals Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top